Global Liposomes Drug Delivery Market Professional Survey Report 2017

December 2017 | 118 pages | ID: GD5E557C960EN
QYResearch

Abstracts

This report studies Liposomes Drug Delivery in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Johnson & Johnson
• Gilead Sciences
• Luye Pharma
• Sun Pharmaceutical
• Pacira
• Fudan-Zhangjiang
• Sigma-Tau Group
• Teva Pharmaceutical
• CSPC
• Novartis
• Crucell
• Celsion Corporation
• Kingond Pharm
• Shanghai New Asia
• Spectrum Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Type I
• Type II

By Application, the market can be split into

• Fungal Infection Therapy
• Cancer Therapy

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Liposomes Drug Delivery Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF LIPOSOMES DRUG DELIVERY

1.1 Definition and Specifications of Liposomes Drug Delivery
  1.1.1 Definition of Liposomes Drug Delivery
  1.1.2 Specifications of Liposomes Drug Delivery
1.2 Classification of Liposomes Drug Delivery
  1.2.1
  1.2.2
1.3 Applications of Liposomes Drug Delivery
  1.3.1 Fungal Infection Therapy
  1.3.2 Cancer Therapy
  1.3.3 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF LIPOSOMES DRUG DELIVERY

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Liposomes Drug Delivery
2.3 Manufacturing Process Analysis of Liposomes Drug Delivery
2.4 Industry Chain Structure of Liposomes Drug Delivery

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF LIPOSOMES DRUG DELIVERY

3.1 Capacity and Commercial Production Date of Global Liposomes Drug Delivery Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Liposomes Drug Delivery Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Liposomes Drug Delivery Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Liposomes Drug Delivery Major Manufacturers in 2016

4 GLOBAL LIPOSOMES DRUG DELIVERY OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Liposomes Drug Delivery Capacity and Growth Rate Analysis
  4.2.2 2016 Liposomes Drug Delivery Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Liposomes Drug Delivery Sales and Growth Rate Analysis
  4.3.2 2016 Liposomes Drug Delivery Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Liposomes Drug Delivery Sales Price
  4.4.2 2016 Liposomes Drug Delivery Sales Price Analysis (Company Segment)

5 LIPOSOMES DRUG DELIVERY REGIONAL MARKET ANALYSIS

5.1 North America Liposomes Drug Delivery Market Analysis
  5.1.1 North America Liposomes Drug Delivery Market Overview
  5.1.2 North America 2012-2017E Liposomes Drug Delivery Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Liposomes Drug Delivery Sales Price Analysis
  5.1.4 North America 2016 Liposomes Drug Delivery Market Share Analysis
5.2 China Liposomes Drug Delivery Market Analysis
  5.2.1 China Liposomes Drug Delivery Market Overview
  5.2.2 China 2012-2017E Liposomes Drug Delivery Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Liposomes Drug Delivery Sales Price Analysis
  5.2.4 China 2016 Liposomes Drug Delivery Market Share Analysis
5.3 Europe Liposomes Drug Delivery Market Analysis
  5.3.1 Europe Liposomes Drug Delivery Market Overview
  5.3.2 Europe 2012-2017E Liposomes Drug Delivery Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Liposomes Drug Delivery Sales Price Analysis
  5.3.4 Europe 2016 Liposomes Drug Delivery Market Share Analysis
5.4 Southeast Asia Liposomes Drug Delivery Market Analysis
  5.4.1 Southeast Asia Liposomes Drug Delivery Market Overview
  5.4.2 Southeast Asia 2012-2017E Liposomes Drug Delivery Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Liposomes Drug Delivery Sales Price Analysis
  5.4.4 Southeast Asia 2016 Liposomes Drug Delivery Market Share Analysis
5.5 Japan Liposomes Drug Delivery Market Analysis
  5.5.1 Japan Liposomes Drug Delivery Market Overview
  5.5.2 Japan 2012-2017E Liposomes Drug Delivery Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Liposomes Drug Delivery Sales Price Analysis
  5.5.4 Japan 2016 Liposomes Drug Delivery Market Share Analysis
5.6 India Liposomes Drug Delivery Market Analysis
  5.6.1 India Liposomes Drug Delivery Market Overview
  5.6.2 India 2012-2017E Liposomes Drug Delivery Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Liposomes Drug Delivery Sales Price Analysis
  5.6.4 India 2016 Liposomes Drug Delivery Market Share Analysis

6 GLOBAL 2012-2017E LIPOSOMES DRUG DELIVERY SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Liposomes Drug Delivery Sales by Type
6.2 Different Types of Liposomes Drug Delivery Product Interview Price Analysis
6.3 Different Types of Liposomes Drug Delivery Product Driving Factors Analysis
  6.3.1 Type I Liposomes Drug Delivery Growth Driving Factor Analysis
  6.3.2 Type II Liposomes Drug Delivery Growth Driving Factor Analysis

7 GLOBAL 2012-2017E LIPOSOMES DRUG DELIVERY SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Liposomes Drug Delivery Consumption by Application
7.2 Different Application of Liposomes Drug Delivery Product Interview Price Analysis
7.3 Different Application of Liposomes Drug Delivery Product Driving Factors Analysis
  7.3.1 Fungal Infection Therapy of Liposomes Drug Delivery Growth Driving Factor Analysis
  7.3.2 Cancer Therapy of Liposomes Drug Delivery Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF LIPOSOMES DRUG DELIVERY

8.1 Johnson & Johnson
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Johnson & Johnson 2016 Liposomes Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Johnson & Johnson 2016 Liposomes Drug Delivery Business Region Distribution Analysis
8.2 Gilead Sciences
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Gilead Sciences 2016 Liposomes Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Gilead Sciences 2016 Liposomes Drug Delivery Business Region Distribution Analysis
8.3 Luye Pharma
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Luye Pharma 2016 Liposomes Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Luye Pharma 2016 Liposomes Drug Delivery Business Region Distribution Analysis
8.4 Sun Pharmaceutical
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Sun Pharmaceutical 2016 Liposomes Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Sun Pharmaceutical 2016 Liposomes Drug Delivery Business Region Distribution Analysis
8.5 Pacira
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Pacira 2016 Liposomes Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Pacira 2016 Liposomes Drug Delivery Business Region Distribution Analysis
8.6 Fudan-Zhangjiang
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Fudan-Zhangjiang 2016 Liposomes Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Fudan-Zhangjiang 2016 Liposomes Drug Delivery Business Region Distribution Analysis
8.7 Sigma-Tau Group
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Sigma-Tau Group 2016 Liposomes Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Sigma-Tau Group 2016 Liposomes Drug Delivery Business Region Distribution Analysis
8.8 Teva Pharmaceutical
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Teva Pharmaceutical 2016 Liposomes Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Teva Pharmaceutical 2016 Liposomes Drug Delivery Business Region Distribution Analysis
8.9 CSPC
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 CSPC 2016 Liposomes Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 CSPC 2016 Liposomes Drug Delivery Business Region Distribution Analysis
8.10 Novartis
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Novartis 2016 Liposomes Drug Delivery Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Novartis 2016 Liposomes Drug Delivery Business Region Distribution Analysis
8.11 Crucell
8.12 Celsion Corporation
8.13 Kingond Pharm
8.14 Shanghai New Asia
8.15 Spectrum Pharmaceuticals

9 DEVELOPMENT TREND OF ANALYSIS OF LIPOSOMES DRUG DELIVERY MARKET

9.1 Global Liposomes Drug Delivery Market Trend Analysis
  9.1.1 Global 2017-2022 Liposomes Drug Delivery Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Liposomes Drug Delivery Sales Price Forecast
9.2 Liposomes Drug Delivery Regional Market Trend
  9.2.1 North America 2017-2022 Liposomes Drug Delivery Consumption Forecast
  9.2.2 China 2017-2022 Liposomes Drug Delivery Consumption Forecast
  9.2.3 Europe 2017-2022 Liposomes Drug Delivery Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Liposomes Drug Delivery Consumption Forecast
  9.2.5 Japan 2017-2022 Liposomes Drug Delivery Consumption Forecast
  9.2.6 India 2017-2022 Liposomes Drug Delivery Consumption Forecast
9.3 Liposomes Drug Delivery Market Trend (Product Type)
9.4 Liposomes Drug Delivery Market Trend (Application)

10 LIPOSOMES DRUG DELIVERY MARKETING TYPE ANALYSIS

10.1 Liposomes Drug Delivery Regional Marketing Type Analysis
10.2 Liposomes Drug Delivery International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Liposomes Drug Delivery by Region
10.4 Liposomes Drug Delivery Supply Chain Analysis

11 CONSUMERS ANALYSIS OF LIPOSOMES DRUG DELIVERY

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL LIPOSOMES DRUG DELIVERY MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Liposomes Drug Delivery
Table Product Specifications of Liposomes Drug Delivery
Table Classification of Liposomes Drug Delivery
Figure Global Production Market Share of Liposomes Drug Delivery by Type in 2016
Figure Type I Picture
Table Major Manufacturers of Type I
Figure Type II Picture
Table Major Manufacturers of Type II
Table Applications of Liposomes Drug Delivery
Figure Global Consumption Volume Market Share of Liposomes Drug Delivery by Application in 2016
Figure Fungal Infection Therapy Examples
Table Major Consumers in Fungal Infection Therapy
Figure Cancer Therapy Examples
Table Major Consumers in Cancer Therapy
Figure Market Share of Liposomes Drug Delivery by Regions
Figure North America Liposomes Drug Delivery Market Size (Million USD) (2012-2022)
Figure China Liposomes Drug Delivery Market Size (Million USD) (2012-2022)
Figure Europe Liposomes Drug Delivery Market Size (Million USD) (2012-2022)
Figure Southeast Asia Liposomes Drug Delivery Market Size (Million USD) (2012-2022)
Figure Japan Liposomes Drug Delivery Market Size (Million USD) (2012-2022)
Figure India Liposomes Drug Delivery Market Size (Million USD) (2012-2022)
Table Liposomes Drug Delivery Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Liposomes Drug Delivery in 2016
Figure Manufacturing Process Analysis of Liposomes Drug Delivery
Figure Industry Chain Structure of Liposomes Drug Delivery
Table Capacity and Commercial Production Date of Global Liposomes Drug Delivery Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Liposomes Drug Delivery Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Liposomes Drug Delivery Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Liposomes Drug Delivery Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Liposomes Drug Delivery 2012-2017
Figure Global 2012-2017E Liposomes Drug Delivery Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Liposomes Drug Delivery Market Size (Value) and Growth Rate
Table 2012-2017E Global Liposomes Drug Delivery Capacity and Growth Rate
Table 2016 Global Liposomes Drug Delivery Capacity (K Units) List (Company Segment)
Table 2012-2017E Global Liposomes Drug Delivery Sales (K Units) and Growth Rate
Table 2016 Global Liposomes Drug Delivery Sales (K Units) List (Company Segment)
Table 2012-2017E Global Liposomes Drug Delivery Sales Price (USD/Unit)
Table 2016 Global Liposomes Drug Delivery Sales Price (USD/Unit) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Units) of Liposomes Drug Delivery 2012-2017E
Figure North America 2012-2017E Liposomes Drug Delivery Sales Price (USD/Unit)
Figure North America 2016 Liposomes Drug Delivery Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Units) of Liposomes Drug Delivery 2012-2017E
Figure China 2012-2017E Liposomes Drug Delivery Sales Price (USD/Unit)
Figure China 2016 Liposomes Drug Delivery Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Units) of Liposomes Drug Delivery 2012-2017E
Figure Europe 2012-2017E Liposomes Drug Delivery Sales Price (USD/Unit)
Figure Europe 2016 Liposomes Drug Delivery Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Units) of Liposomes Drug Delivery 2012-2017E
Figure Southeast Asia 2012-2017E Liposomes Drug Delivery Sales Price (USD/Unit)
Figure Southeast Asia 2016 Liposomes Drug Delivery Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Units) of Liposomes Drug Delivery 2012-2017E
Figure Japan 2012-2017E Liposomes Drug Delivery Sales Price (USD/Unit)
Figure Japan 2016 Liposomes Drug Delivery Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Units) of Liposomes Drug Delivery 2012-2017E
Figure India 2012-2017E Liposomes Drug Delivery Sales Price (USD/Unit)
Figure India 2016 Liposomes Drug Delivery Sales Market Share
Table Global 2012-2017E Liposomes Drug Delivery Sales (K Units) by Type
Table Different Types Liposomes Drug Delivery Product Interview Price
Table Global 2012-2017E Liposomes Drug Delivery Sales (K Units) by Application
Table Different Application Liposomes Drug Delivery Product Interview Price
Table Johnson & Johnson Information List
Table Product A Overview
Table Product B Overview
Table 2016 Johnson & Johnson Liposomes Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Johnson & Johnson Liposomes Drug Delivery Business Region Distribution
Table Gilead Sciences Information List
Table Product A Overview
Table Product B Overview
Table 2016 Gilead Sciences Liposomes Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Gilead Sciences Liposomes Drug Delivery Business Region Distribution
Table Luye Pharma Information List
Table Product A Overview
Table Product B Overview
Table 2015 Luye Pharma Liposomes Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Luye Pharma Liposomes Drug Delivery Business Region Distribution
Table Sun Pharmaceutical Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sun Pharmaceutical Liposomes Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Sun Pharmaceutical Liposomes Drug Delivery Business Region Distribution
Table Pacira Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pacira Liposomes Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Pacira Liposomes Drug Delivery Business Region Distribution
Table Fudan-Zhangjiang Information List
Table Product A Overview
Table Product B Overview
Table 2016 Fudan-Zhangjiang Liposomes Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Fudan-Zhangjiang Liposomes Drug Delivery Business Region Distribution
Table Sigma-Tau Group Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sigma-Tau Group Liposomes Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Sigma-Tau Group Liposomes Drug Delivery Business Region Distribution
Table Teva Pharmaceutical Information List
Table Product A Overview
Table Product B Overview
Table 2016 Teva Pharmaceutical Liposomes Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Teva Pharmaceutical Liposomes Drug Delivery Business Region Distribution
Table CSPC Information List
Table Product A Overview
Table Product B Overview
Table 2016 CSPC Liposomes Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 CSPC Liposomes Drug Delivery Business Region Distribution
Table Novartis Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis Liposomes Drug Delivery Revenue (Million USD), Sales (K Units), Ex-factory Price (USD/Unit)
Figure 2016 Novartis Liposomes Drug Delivery Business Region Distribution
Table Crucell Information List
Table Celsion Corporation Information List
Table Kingond Pharm Information List
Table Shanghai New Asia Information List
Table Spectrum Pharmaceuticals Information List
Figure Global 2017-2022 Liposomes Drug Delivery Market Size (K Units) and Growth Rate Forecast
Figure Global 2017-2022 Liposomes Drug Delivery Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Liposomes Drug Delivery Sales Price (USD/Unit) Forecast
Figure North America 2017-2022 Liposomes Drug Delivery Consumption Volume (K Units) and Growth Rate Forecast
Figure China 2017-2022 Liposomes Drug Delivery Consumption Volume (K Units) and Growth Rate Forecast
Figure Europe 2017-2022 Liposomes Drug Delivery Consumption Volume (K Units) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Liposomes Drug Delivery Consumption Volume (K Units) and Growth Rate Forecast
Figure Japan 2017-2022 Liposomes Drug Delivery Consumption Volume (K Units) and Growth Rate Forecast
Figure India 2017-2022 Liposomes Drug Delivery Consumption Volume (K Units) and Growth Rate Forecast
Table Global Sales Volume (K Units) of Liposomes Drug Delivery by Type 2017-2022
Table Global Consumption Volume (K Units) of Liposomes Drug Delivery by Application 2017-2022
Table Traders or Distributors with Contact Information of Liposomes Drug Delivery by Region